The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, me🔥dical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and resi🌼dential care facilities.
Although quite different in terms of political and economic systems, the Emerging Europe countries share certain similarities when it comes to their demographic situation and health profile. With t💜he exception of Turkey, whose average birth rate is ...
168极速一分钟赛车视频记录:View more detailsThe changing demographic and disease profi♚les of Hungary were the drivers of the expansion of health expenditure in recent years. As a result, the country spent 7.4% of its🦂 GDP on healthcare in 2016, still below the EU average. The government ...
168极速一分钟赛车视频记录:View more detailsTurkey’s healthcare syste🔜m has been fully reformed under the 2003-201♈3 Health Transformation Programme (HTP), which helped expand the coverage and quality of health services across the country. Health insurance coverage reached 98.4% of the ...
168极速一分钟赛车视频记录:View more detailsThe economy’s return to growth provided a ♎strong impetus to the Russian healthcare sector in 2017. Healthcare expenditure grew by a robust 22% y/y, when measured in US dollar terms, the first increase in many years. However, at USD 92bn in 2017 ...
168极速一分钟赛车视频记录:View more detailsThe gross value added (GVA) of the Czech pharmaceutical sector amounted to CZK 19.4bn in 2017, increasing by♛ 🌺a real 11.1% y/y. The sector accounted for 0.4% of the GDP that year. The pharmaceutical sector employed 9,855 workers in 2017, accounting ...
168极速一分钟赛车视频记录:View more detailsTurkey’s heal💧th insurance coverage reaches 98.4% of the population, according to the OECD Health Statistics 2017. The state, through the Ministry of Health (MoH), is the main provider of health services in the country, which still has very low ...
168极速一分钟赛车视频记录:View more detailsExpenditure on healthcare in Romania reached RON 35.2bn in 2015, according to dat🌸a provided by Eurostat. Total expenditure on healthcare was equal to 4.94% of GDP in that year. The Romanian healthcare sector was charac𝓡terised by the lowest per capita ...
168极速一分钟赛车视频记录:View more detailsTotal ♚expenditure on healthcare in Hungary in 2015 reached HUF 2,460b🔯n, up by 6.3% y/y. Government and compulsory health care financing schemes made up 67% of the expenditure, followed by private out-of-pocket spending (29%). Voluntary healthcare ...
168极速一分钟赛车视频记录:View more detailsIn 2016 Poland’s healthcare expenditure grew by 4.5% y/y to PLN 119.27bn, representing 6.4% of the GDP. P🦄ublic healthcare spending in Poland is one of the lowest compared to the EU average, which hovers around 6.5 % of GDP. The bulk of the ...
168极速一分钟赛车视频记录:View more detailsRussia’s healthcare and pharmaceutical sector was badly affected by the 20𒈔15-2016 recession, which resulted in a sharp drop in government spending, while the weak rouble and high inflation cut into households’ disposable incomes. Though ...
168极速一分钟赛车视频记录:View more details